AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
An efficient neural screening approach rapidly identifies circuit modules governing distinct behavioral transitions in response to pathogen exposure.
Save this article to read it later. Find this story in your account’s ‘Saved for Later’ section. Now, due in large part to Team Trump’s ineptitude, the Epstein files have become the biggest ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results